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Systemic Macrophage Depletion Inhibits Helicobacter bilis-Induced
Proinflammatory Cytokine-Mediated Typhlocolitis and Impairs
Bacterial Colonization Dynamics in a BALB/c Rag2/ Mouse Model
of Inflammatory Bowel Disease
Sureshkumar Muthupalani,a Zhongming Ge,a Yan Feng,a Barry Rickman,a Melissa Mobley,a Amanda McCabe,a Nico Van Rooijen,b and
James G. Foxa,c
Division of Comparative Medicinea and Department of Biological Engineering,c Massachusetts Institute of Technology, Cambridge, Massachusetts, USA, and Department
of Molecular Cell Biology, Vrije Universiteit Medical Center, Amsterdam, Netherlandsb
Helicobacter bilis, an enterohepatic helicobacter, is associated with chronic hepatitis in aged immunocompetent inbred mice
and inflammatory bowel disease (IBD) in immunodeficient mice. To evaluate the role of macrophages inH. bilis-induced IBD,
Rag2/ BALB/c or wild-type (WT) BALB/c mice were either sham dosed or infected withH. bilisMissouri strain under specific-
pathogen-free conditions, followed by an intravenous injection of a 0.2-ml suspension of liposomes coated with either phos-
phate-buffered saline (control) or clodronate (a macrophage depleting drug) at 15 weeks postinfection (wpi). At 16 wpi, the ceca
ofH. bilis-infected Rag2/mice treated with control liposomes had significantly higher histopathological lesional scores (for
cumulative typhlitis index, inflammation, edema, epithelial defects, and hyperplasia) and higher counts of F4/80macrophages
andMPO neutrophils compared toH. bilis-infected Rag2/mice treated with clodronate liposomes. In addition, cecal quanti-
tative PCR analyses revealed a significant suppression in the expression of macrophage-related cytokine genes, namely, Tnfa,
Il-1, Il-10, Cxcl1, and iNos, in the clodronate-treatedH. bilis-infected Rag2/mice compared to theH. bilis-infected Rag2/
control mice. Finally, cecal quantitative PCR analyses also revealed a significant reduction in bacterial colonization in the clo-
dronate-treated Rag2/mice. Taken together, our results suggest that macrophages are critical inflammatory cellular media-
tors for promotingH. bilis-induced typhlocolitis in mice.
Inflammatory bowel disease (IBD) constitutes spectra of chronic,idiopathic, and relapsing complex multifactorial inflammatory
disorders of the gastrointestinal tract in humans with two well-
recognized clinicopathological manifestations, namely, ulcerative
colitis andCrohn’s disease. Both of these conditions are associated
with an increased risk of developing colitis associated colorectal
cancers (21, 42, 38, 53). Various mouse models to study IBD in-
clude spontaneous colitis models, chemically induced colitis
models, adoptive cell transfer models, colitis in immunodeficient
mice, or genetically engineered models or any combination of
these models (8, 12, 22, 29, 32, 35, 50, 51). Epidemiological data
and animal models of IBD implicate a dynamic interplay of mul-
tiple factors, including genetic susceptibility, intestinal micro-
biota, host innate and adaptive immune components, and envi-
ronmental effects in the pathogenesis of IBD and colitis-
associated carcinogenesis (1, 4, 7, 12, 22, 38, 53).
Commensal gutmicrobiota are key players in the development
and maintenance of the host gastrointestinal immune homeosta-
sis and in the initiation of IBD following enteric mucosal damage
observed with infections, chemicals such as dextran sodium sul-
fate (DSS), drug toxicities, radiation therapy, and antibiotic ther-
apy (1, 22, 32, 37). Among the gut microflora are members of the
enterohepatic Helicobacter species (EHS) that are prevalent in
mice housed in academic facilities (44, 45, 46, 47). Of these,Heli-
cobacter hepaticus is the best studied in terms of its ability to cause
murine strain-dependent hepatitis and IBD, as well hepatic and
colon cancers in Il-10/ mice, SCID mice (lacks T and B cells),
and Rag2/mice (lacks functional lymphocytes) (12). H. bilis is
another Gram-negative, microaerophilic EHS that was first iso-
lated from the livers and intestines of aged inbred strains of mice
with hepatitis (15) and subsequently from the livers of outbred
mice (13). H. bilis causes typhlocolitis and/or cholangiohepatitis
in a variety of immunocompromised mice, including SCID, Il-
10/, Mdr1a/, and TCR/ mice (12, 29, 45). H. bilis or H.
hepaticus infection in 129-Smad3tm/Par/J (referred to as
Smad3/) mice leads to the development of colitis-associated
mucinous colonic adenocarcinoma that is strongly correlated
with the expression of Il-1b, Mip-1a, and Cd5 (RANTES) (9). H.
bilis is also associatedwith proliferative typhlocolitis, chronic hep-
atitis, hepatic dysplasia, and biliary hyperplasia in aged Syrian
hamsters (14), as well as IBD/colitis in athymic nude rats (20).
Further, H. bilis has been incriminated to play a role in human
cholecystitis and gallbladder cancer from studies in Japan, Thai-
land, and Chile (11, 24, 34). In immunocompetent mice (C3H)
mice with defined microbiota, H. bilis infection—even in the ab-
sence of overt colitis—results in a significant increase in the ex-
pression pattern of a plethora of mucosal genes, including those
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involved in lymphocyte activation (e.g., Cd28 and Tnfsf13b) and
regulation (e.g., Il-17a) and in inflammatory cell chemotaxis (e.g.,
Itgb2, Ccl8, and Ccr5) (27). Importantly, H. bilis can cause the
exacerbation of DSS-induced colitis, as shown in a study using
C3H/HeN:TACmice colonized with defined microflora (28). Re-
cent studies in our laboratory performed in C57BL/6 mice have
highlighted the role of EHS,H. bilis,H.muridarum, andH. hepati-
cus in immunomodulating the pathogenesis ofH. pylori via a Th17
regulatory pathway (18, 26).
Specialized gut-resident dendritic cells (DCs) and macro-
phages display remarkable plasticity and partial overlap in their
functionality, phenotypes, and expression of various cellular
markers, such as Cd11b (macrophages, both positive and negative
DCs), Cd11c (DCs chiefly, some macrophage subsets), Cd103
(both positive and negative DCs), Cd8, Cd45, and F4/80 (mac-
rophages chiefly, some DC subsets), depending upon their loca-
tion and individual subset population (5, 10, 19, 37, 40). Both
macrophages and DCs are key players in the immune defense
against both commensal and pathogens and aremodulators of the
regulatory T cell population (5, 10, 19, 40). In IBD, macrophages
within the inflamed mucosa are derived from mainly circulating
macrophages and, upon stimulation, secrete various proinflam-
matory cytokines, such as interleukin-1 (IL-1), IL-6, IL-8, IL-12,
IL-18, and tumor necrosis factor alpha (TNF-), all of which can
mediate the associated pathology (41, 53).Macrophages and other
phagocytes, primarily DCs and neutrophils, mediate the release of
reactive oxygen species, including myeloperoxidase (MPO) (pre-
dominantly from neutrophils) and nitric oxide (from macro-
phages), with purported direct epithelial injury and a battery of
subcellular and molecular damage to DNA, RNA, protein, lipids,
and metabolites in IBD and colon cancer in humans and animal
models (2, 7, 21, 28, 33, 48).
Selective macrophage depletion, by means of the macrophage
suicide technique utilizing liposome-mediated intracellular deliv-
ery of dichloromethylene-biphosphonate (Cl2MBP [clodronate])
is a well-established experimental protocol that is routinely used
to address the contribution of innate immune cells in the patho-
genesis of inflammatory disorders (35, 36, 49, 50). Depending
upon the route of administration, the liposomes containing clo-
dronate are rapidly engulfed by professional phagocytes, chiefly
macrophages and certain subsets of DCs, in various tissues, lead-
ing to the formation of an endosome (49, 52). The next set of
events in the ingested macrophages include the fusion of the en-
dosome with the phagosome, resulting in the formation of a
phagolysosome with low pH, followed by the activation of phos-
pholipases, leading to the degradation of phagolysosomal mem-
branes and the release of free clodronate into the cytosol (49, 52).
Free clodronate is a negatively charged, readily diffusible, water-
soluble biphosphonate that chemically mimics cellular pyrophos-
phates and is acted upon by several class II aminoacyl-tRNA syn-
thetases to produce a nonhydrolyzable ATP analog, namely,
adenosine 5=-(,-dichloromethylene)triphosphate (AppCCl2p)
(25, 49, 52). AppCCl2p is toxic to cells and is presumed to cross the
outer mitochondrial membrane leaflets and irreversibly binds to
and inactivates ATP/ADP translocases on the inner membrane,
leading to membrane pore formation, loss of mitochondrial
membrane integrity, mitochondrial depolarization, and caspase-
mediated apoptotic cell death (25). Systemically administered clo-
dronate in encapsulated liposome form is rapidly cleared from the
blood within hours by means of uptake by different subtypes of
macrophages in the liver, spleen, lymph nodes, gut, lungs, and
other organs. Clodronate-mediated macrophage apoptotic cellu-
lar debris is usually seen only during the first 2 days posttreatment,
and hence in vivo experimental analyses are usually performed 2
or more days after clodronate treatment (49, 52).
Various experimental studies have successfully used the clo-
dronate liposome-mediated strategy as a tool to study the role
of macrophages in different settings of IBD (35, 36, 50, 52).
These include the systemic depletion of macrophages and DCs,
as well as local depletion of these cells by rectal administration
in different settings of DSS colitis in various immunodeficient
murine strains. Specifically, studies of IL-10 knockout (KO)
mice, SHIP/ mice (i.e., deficient in the hematopoiesis-spe-
cific negative regulator of the phosphatidylinositol 3-kinase
pathway, skewed macrophage [M2a] phenotype), and CD11c-
DTR transgenic mice (i.e., deficient in DCs) have highlighted
the importance of these cells in the pathogenesis of IBD (30, 35,
36, 50, 51, 52).
In the present study, we evaluated the effect of systemic
depletion of macrophages via administration of clodronate in
an encapsulated liposome form in a Rag2/ murine model of
H. bilis-induced typhlocolitis. The impact of macrophage de-
pletion was assessed in terms ofH. bilis-induced overall typhlo-
colitis, intestinal tissue cytokine profiles, and H. bilis coloniza-
tion dynamics.
MATERIALS AND METHODS
Bacterial culture, DNA preparation, and quantitative PCR forH. bilis.
H. bilisMissouri strain was cultured undermicroaerobic conditions (80%
N2, 10% H2, 10% CO2) at 37°C on Columbia blood agar plates (Remel
Laboratories) for 3 to 4 days. For experimental inoculation, the bacterial
density was adjusted to 109 per ml in phosphate-buffered saline (PBS)
on the basis of an optical density at 600 nm of 1. Mice were orally gavaged
with 0.2 ml (2  108 organisms) of an H. bilis suspension every other
day for three doses. The DNAwas extracted from the culturedH. bilis and
from cecal tissues by use of a High-Pure PCR template preparation kit
(RocheMolecular Biochemicals, Indianapolis, IN). Cecal levels ofH. bilis
were measured and normalized in reference to mouse DNA using quan-
titative PCR as previously described (26).
In vivo H. bilis infection and macrophage depletion. Wild-type
(WT) BALB/c mice or Rag2/ BALB/c mice obtained from Taconic
Farms (Germantown,NY)were housed in groups of five in polycarbonate
microisolator cages on hardwood bedding (PharmaServ, Framingham,
MA) under specific-pathogen-free conditions (free of Helicobacter spp.,
Citrobacter rodentium, Salmonella spp., endoparasites, ectoparasites, and
exogenous murine viral pathogens). All animals were housed in an Asso-
ciation for Assessment and Accreditation of Laboratory Animal Care
(AAALAC) International-accredited facility, and all animal experimental
protocols approved by the MIT Committee on Animal Care. Mice were
maintained at standard conditions of 70  2°F in 30 to 70% relative
humidity with a 12-h/12-h light/dark cycle, were fed standard rodent
chow (Purina Mills, St. Louis, MO), and were provided with water ad
libitum. A total of 52 animals were used in the study, and these animals
were divided among various treatment groups as outlined in Table 1.
These were divided into animals infected with H. bilis as described above
or uninfected animals with either WT or Rag2/ backgrounds. Infected
mice or sham-dosed mice were maintained for 14 to 16 weeks postinfec-
tion (wpi) under specific-pathogen-free conditions prior to euthanasia
and postmortem examination. A subset of mice from both WT and
Rag2/ backgrounds at exactly 7 days prior to their euthanasia were
administered intravenously via tail vein a suspension of 0.2 ml containing
either clodronate-encapsulated liposomes (active form) or PBS-coated
liposomes (inactive form) to serve as a control. Clodronate (Roche Diag-
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nostics GmbH, Mannheim, Germany) at a concentration of 0.25 g/ml of
PBS was encapsulated in liposomes according to an established protocol
as described previously (49, 52).
Necropsy and histopathology. At necropsy, a complete gross exami-
nation of abdominal and thoracic organs was performed. Representative
samples of feces, stomachs, ceca, colons, livers, and gallbladders were
collected in freeze medium for culture and/or PCR, and the tissues were
fixed in 10%neutral buffered formalin for routine histological processing.
Hematoxylin-eosin (H&E)-stained sections of the cecum, including the
junctions of the cecum, ileum, and proximal colon, colon (proximal,
transverse, and distal colon), and liver were evaluated by two board-cer-
tified comparative pathologists (B. Rickman and S. Muthupalani), who
were blinded to sample identity as described previously (39). Briefly, the
intestinal sections were scored on a scale of 0 to 4 for inflammation,
epithelial defects, crypt atrophy, hyperplasia, and dysplasia/neoplasia, and
the cumulative scores were represented as either the colitis index or the
typhlitis index. Liver sections were examined in on a scale of 0 to 4 for
inflammation.
Immunohistochemistry. Using previously established protocols, we
evaluated macrophages, neutrophils, and DCs in intestinal tissue sections
by avidin-biotin complex immunohistochemistrywith antibodies specific
forMPO (1:75; RB-373-A [Thermo Scientific]), a predominantly neutro-
phil-specific marker; F4/80 (1:150; MF48015 [Caltag Laboratories]), a
macrophage-specific marker; and S100 (1:40; AbD Serotec, Inc.), a neu-
roglial marker that also identifies DC subsets) (43). Briefly, ileocecal and
colonic sections from 10 randomly selected animals (five males and five
females) per group for each different time point were analyzed. Five ran-
domly selected, full-thickness mucosal segments at a 40 objective field
magnification per mouse were screened to quantify the total number im-
munopositive cells in themucosa and submucosa. The data were analyzed
using unpaired Student t test, and the values were plotted as the average
number of positive cells/40 high-power objective field (HPF).
Tissue cytokines. To correlate the histopathological lesion severity
with the inflammatory molecular markers, we analyzed cytokine gene
expression levels in the cecum. One-centimeter segments f cecum near
the junction were harvested immediately after mice were euthanized, and
the segments were snap-frozen in liquid nitrogen. The total RNA from
cecal samples were prepared using TRIzol reagents by following the man-
ufacturer’s instructions (Invitrogen, Carlsbad, CA). cDNA from cecal
mRNA (2 	g) was reverse transcribed by using a High-Capacity cDNA
archive kit (Applied Biosystems, Foster City, CA) according to the suppli-
er’s instructions. The transcript levels of IL-1, TNF-, IL-10, Cox2,
iNOS, and Cxcl1 in individual samples of the cecum were measured by
quantitative PCR using TaqMan gene expression assays in the ABI Prism
sequence detection system 7500 Fast (Applied Biosystems). Cecal RNA
from all individual mice from the various infected and uninfected groups
(both WT and Rag2/mice) with or without clodronate treatment was
used for individual cytokine analyses. WT and Rag2/mice were com-
pared separately for statistical purposes, and the uninfected mice from
each genotype served as their respective controls. All target genes were
normalized to the endogenous control glyceraldehyde-3-phosphate dehy-
drogenase (GAPDH)mRNA and expressed as fold changes in reference to
sham-dosed control mice using the comparative threshold cycle (CT)
method (Applied Biosystems, User Bulletin No. 2).
Statistical analysis. Statistical analyses of nonparametric histopatho-
logical scores was performed using the Mann-Whitney U test and are
represented as median values with upper and lower quartiles. Immuno-
histochemical quantitative data between different groups was analyzed
using the unpaired Student t test and are presented as means the stan-
dard errors of the mean. The cytokine data were analyzed using a two-
tailed Student t test. For all analyses, a P value of 
0.05 was considered
statistically significant. All analyses were performed using Prism software
(GraphPad, San Diego, CA).
RESULTS
Systemic macrophage depletion attenuated typhlocolonic in-
flammation in H. bilis-infected Rag2/ mice. In this experi-
ment, the ceca and colons of various experimental animals with
differences in genetic background (BALB/c WT or BALB/c
Rag2/ mice), infection status (with or without H. bilis), and
treatment type (control liposomes encapsulated with PBS or lipo-
somes encapsulated with clodronate) were systematically evalu-
ated for the changes in the various histomorphological parame-
ters. As shown in Fig. 1a, theH. bilis-infected Rag2/mice (n
13) at 16 wpi treated with control (PBS) liposomes (7 days post-
treatment) had significantly higher overall typhlitis index scores
thanH. bilis-infected Rag2/mice (n 13) (P 0.002) treated
with clodronate-encapsulated liposomes. Although not statisti-
cally significant, a similar trend was also observed in the colon
with respect to the overall colitis index scores between the twoH.
bilis-infected groups (Fig. 1b). For the cecum, histological lesions
were reflected in significantly higher scores for inflammation (P
0.001), edema (P  0.015), epithelial defects (P 
 0.0001), and
hyperplasia (P  0.004) in PBS (placebo) liposome H. bilis-in-
fected mice compared to clodronate liposome-treated infected
mice (Fig. 2). The degree of typhlitis in the PBS-treated H. bilis-
infected Rag2/ mice ranged from mild to moderate mixed in-
flammation composed predominantly of macrophages, neutro-
phils, and eosinophils (score range, 1 to 2; median, 1; mean, 1.3)
with associated mild edema (range, 0 to 2; median, 0; mean, 0.8),
mild epithelial defects (range, 0.5 to1; median, 1; mean, 0.9), and
mild to moderate hyperplasia (range, 0 to 3; median, 1; mean, 1).
In comparison, systemic depletion of macrophages in H. bilis-
infected Rag2/ mice resulted in no to minimal inflammation
(range, 0 to 1; median, 0; mean, 0.3), minimal edema (range, 0 to
1; median, 0; mean, 0.3), minimal epithelial defects (range, 0 to 1;
median, 0; mean, 0.2), and no tominimal hyperplasia (range, 0 to
1; median, 0; mean, 0.19). In both of these groups, crypt atrophy
and dysplasia were mostly inconsequential, except in one infected
PBS-treatedmouse that exhibitedminimal cecal epithelial dyspla-
sia (Fig. 2 and 3). The trend for higher colonic lesional index
scores in control liposome-treated infected mice was reflected by
marginally higher scores in the categories of inflammation, epi-
TABLE 1 Experimental mice, H. bilis infection status, and treatments
Mouse strain
Uninfected mice H. bilis-infected mice
Treatment No. of animals Treatment No. of animals
BALB/c WT Clodronate liposomes 5 Clodronate liposomes 2
Control (PBS) liposomes 5 Control (PBS) liposomes 4
BALB/c Rag2/ Clodronate liposomes 5 Clodronate liposomes 13 (9 M, 4 F)
Control (PBS) liposomes 5 Control (PBS) liposomes 13 (9 M, 4 F)
Muthupalani et al.
4390 iai.asm.org Infection and Immunity
 o
n
 M
ay 2, 2013 by Vrije Universiteit, Medical Library
http://iai.asm
.org/
D
ow
nloaded from
 
thelial defects, and hyperplasia compared to clodronate liposome-
treated mice (data not shown).
Additional controls for the experiment included uninfected
WT (BALB/c) treated with either control (PBS) liposomes (n 5)
or clodronate-encapsulated liposomes (n  5) and WT H. bilis-
infected mice treated with either control (PBS) liposomes (n 5)
or clodronate-encapsulated liposomes (n  5), as well as unin-
fectedRag2/mice treated with either control liposomes (n 4)
or clodronate-encapsulated liposomes (n  2). As expected in
these various groups of control mice, the ceca and colons of most
animals were normal except for minimal inflammation and/or
associated changes in a few, as shown by the cumulative lesion
indices in Fig. 1. Also, the livers of H. bilis-infected mice did not
show any significant inflammation or other pathological altera-
tions.
Clodronate treatment in H. bilis-infected Rag2/ mice re-
sulted in a significant reduction in cecal macrophage and neu-
trophil counts. In addition, by quantitative immunohistochemi-
cal analysis, we observed that the clodronate liposome-treated H.
bilis-infected Rag2/ mice had significantly decreased numbers
of F4/80macrophages colonizing the cecal mucosa than control
liposome-treatedH. bilis-infectedRag2/mice (P 0.004, n 6
[clodronate versus control]; means  the standard deviations
[SD], 49.5 8 versus 32.3 3.8, per 40HPF) (Fig. 4). Interest-
ingly, given the importance of macrophages in chemokine pro-
duction (e.g., Cxcl1) and neutrophil influx during IBD and other
inflammatory states (6, 34, 41, 46), the systemic depletion of mac-
rophages in H. bilis-infected Rag2/ mice in the present study
also resulted in a significant reduction (P 
 0.015) in cecal neu-
trophil counts compared to their placebo (PBS) liposome-treated
counterparts (Fig. 4). Upon S100 immunostaining, we observed
positive staining of DCs (on the basis of morphology) in the mu-
cosae ofH. bilis-infected animals, and this was decreased in mag-
nitude in clodronate-treated H. bilis-infected animals, although
some cross-reactivity was also observed in few neutrophils (hence,
the data are not presented).
Reduction of intestinal macrophages counts in clodronate-
treated H. bilis-infected Rag2/ mice is correlated with a sig-
nificant suppressionofmacrophage-related inflammatory cyto-
kines. To evaluate the importance of macrophages and related
cytokines in this model ofH. bilis-induced typhlocolitis, the tran-
script levels of select cytokines and chemokines were measured at
16 wpi by quantitative PCR in the cecal tissues of both Rag2/
mice and WT mice intravenously treated with clodronate. These
findingswere correlatedwith histopathological disease severity. In
the clodronate-treatedH. bilis-infected Rag2/mice, there was a
significant suppression in the cecal mRNA levels of the cytokines,
expressed predominantly or acted upon by the monocyte/macro-
phage lineage, compared toH. bilis-infectedRag2/mice treated
with PBS-coated (placebo) liposomes (Fig. 5). Briefly, the cyto-
kine genes that were transcriptionally suppressed in the clodro-
nate-treated H. bilis-infected Rag2/ group included IL-1 (an
important proinflammatory mediator produced by activated
macrophages, also an inducer of Cox2) (P
 0.0001) and TNF-
(a proinflammatory cytokine produced by activatedmacrophages
and involved in systemic inflammatory response) (P  0.007).
Also, decreased were IL-10 (an anti-inflammatory cytokine with
pleotrophic effects produced by macrophages and lymphocytes)
(P  0.037), iNOS (an inducible nitric oxide synthase produced
by activated macrophages and epithelial cells and important in
innate immunedefense against pathogens) (P 0.025), andCxcl1
(a neutrophil chemoattractant produced by macrophages, neu-
trophils, and epithelial cells) (P 0.0069). Interestingly, in theH.
bilis-infected Rag2/mice that were treated with clodronate, the
mRNA levels of various cytokines were suppressed to the extent
that these values were not significantly different from those ob-
served with uninfected Rag2/ controls. However, the mRNA
levels of the Cox2 gene in all three different groups were compa-
rable, implying the lack of a direct effect of macrophage depletion
on the levels of Cox2 gene expression in the cecum. A similar
comparative analysis of the expression levels of various cytokines
was performed on the data obtained from WT mice that were
either uninfected (control) or those infected with H. bilis and
treated with clodronate-encapsulated liposomes or PBS (placebo)-
encapsulated liposomes. As expected, given the lack of any pathol-
ogy in the ceca of allWTmice, there was no difference in the levels
of these select gene targets irrespective of infection or clodronate
treatment (data not shown).
Colonization levels ofH. bilis in the cecum of Rag2/mice
is significantly decreased uponmacrophage depletion. Interest-
FIG 1 Cecal (a) or colonic (b) tissues ofH. bilis-infected or uninfected (sham)
BALB/c mice of both Rag2/ (Rag2KO) or wild-type (WT) backgrounds
treated with either control (PBS) liposomes or clodronate (Clod) were histo-
logically graded at 16 wpi for inflammation, edema, epithelial defects, crypt
atrophy, hyperplasia, and dysplasia, and the cumulative scores are represented
as typhlitis or colitis index, respectively. Clodronate treatment significantly
attenuated H. bilis-induced typhlitis in Rag2/ mice, and no significant pa-
thology was observed in both infected and uninfectedWT animals. Individual
bars represent themedian scores with interquartile ranges (*, P
 0.05; **, P

0.01; ***, P
 0.001).
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ingly, as shown in the H. bilis quantitative PCR data presented in
Fig. 6, systemic depletion of macrophages negatively impacted
(P
 0.05) the colonization ability ofH. bilis in the Rag2/mice
compared to the PBS (placebo)-treated Rag2/mice. In the WT
mice, there was no discernible effect of macrophage depletion on
the levels of H. bilis colonization. The levels of colonization in
both the macrophage-depleted (clodronate liposome) and the
nondepleted (PBS liposome) groups of WT type mice were simi-
FIG 2 Individual cecal histopathological parameter scores for inflammation, edema, epithelial defects, crypt atrophy, hyperplasia, and dysplasia and cumulative
typhlitis index inH. bilis-infected Rag2/ (Rag2KO) mice at 16 wpi treated with either clodronate or PBS (placebo)-encapsulated liposomes (7 days posttreat-
ment). Individual bars represent median scores with interquartile ranges, and the P values are shown when significant (*, P
 0.05; **, P
 0.01; ***, P
 0.001).
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lar, highlighting thatH. bilis colonization alone is not sufficient to
induce significant typhlocolitis in immunocompetent mice with
functional immune systems.
DISCUSSION
The innate immune cells—macrophages, DCs, and neutrophils—
are considered to be a prime cellular component of the chronic
proinflammatory state of the gut and, during the course of IBD,
depletion ofmacrophages promotes positive therapeutic effects in
humans and experimental mice (5, 10, 35, 36, 53). Experimental
or therapeutic clinical trials using selective leukocytopharesis or
depletion strategies for the depletion of granulocytes and/or
monocytes are considered to be safe with various levels of efficacy
on mucosal healing (16, 42). In the present study, by utilizing
Rag2/ mice that are deficient in functional T and B cells, we
analyzed the contribution of innate immune components in a
FIG 3 Representative H&E-stained images of the ceca fromH. bilis-infected Rag2/ (Rag2KO)mice at 16 wpi treated with either control (PBS) liposome (a to
d) or clodronate-encapsulated liposomes (e and f). (a) Low-power magnification of the cecum from an H. bilis-infected mice treated with PBS liposomes
(control) showing mucosal thickening from expansion of lamina propria by inflammatory aggregates (star), mild epithelial hyperplasia, and mucosal vascular
congestion. (b) Higher magnification of the cecum from another H. bilis-infected control animal showing prominent mucosal and submucosal infiltrates of
macrophages and granulocytes (arrowhead), submucosal edema (star), and glandular hyperplasia and loss of normal epithelial mucous (arrow). (c) Low-
magnification image of anH. bilis-infected control cecum with moderate inflammation, epithelial hyperplasia, and mild epithelial defects. (d) Higher magnifi-
cation of the image in panel c showing moderate lamina propria expansion by inflammatory cells, mild surface epithelial tethering/loss (thin arrow), occasional
mild glandular luminal distension and loss of epithelial mucous (arrowhead), and hyperplastic glandular and surface epithelium with mild architectural
disorientation (thick arrows). (e and f) Images showing the ceca ofH. bilis-infected Rag2/mice treated with clodronate liposomes at both low-power (e) and
high-power (f) magnifications showing a high degree ofmucosal recovery andminimal pathology, as characterized by low numbers of inflammatory cells, a high
degree of preservation of epithelial mucous, and an absence of significant hyperplasia and other associated changes. Scale bars: a, d, and e, 75	m; b and f, 40	m;
c, 150 	m.
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murine IBD-like state. Our study clearly demonstrates the bene-
ficial effects of a systemic macrophage depletion strategy during
the course of H. bilis-induced typhlocolitis. These data are also
consistent with an earlier study from our laboratory that revealed
thatmacrophages were amajor inflammatory cellular component
during the course of H. bilis-induced typhlocolitis in [Tac:Icr:
Ha(ICR)-scidfDF] Scidmice (46). Cecal cytokine data in the cur-
rent study showed thatH. bilis infection in Rag2/mice by itself
enhances the gene expression levels of IL-10, TNF-, IL-1,
Cxcl1, and iNOS and, correspondingly, depletion ofmacrophages
also simultaneously resulted in a significant reduction of all of
these transcripts with an associated decrease in cecal MPO cell
counts (chiefly neutrophils).
Macrophages may be classified as classically activated macro-
phages (CAMs or M1), which are important for microbicidal ac-
tivity, or alternatively activated macrophages (AAMs orM2), that
in turn can be further subdivided into wound healing macro-
phages (for tissue repair) or regulatorymacrophages (anti-inflam-
matory role) (10, 19). CAMs are formed in response toTNF- and
IFN- and are associated with Th1-mediated responses, including
the secretion of TNF-, IL-1, IL-6, IL-12, and IL-23, the activation
of the Th17 pathway, and the induction of IL-17 and iNOS, a
potent chemoattractant for neutrophils (2, 5, 10, 19, 37).Wound-
healing macrophages are important in tissue repair and produced
in response to stimulation by IL-4 via Th2 helper cell activation or
elaborated from basophils/granulocytes following tissue injury or
contact with chitin, all of which result in an increased production
of collagen and extracellular matrix with a concomitant decrease
in tissue iNOS levels (5, 10, 19, 37). Regulatory macrophages are
activated in response to various stimuli, including immune com-
FIG 4 Cecal F4/80 and MPO immunohistochemistry. Five well-oriented 40 objective microscopic fields from immunostained cecal sections of H.
bilis-infected Rag2/ mice (n  6 per group) treated with either clodronate or placebo (PBS) were quantitatively assessed for the total numbers of F4/80
macrophages (top left and middle left panels, respectively) andMPO cells (neutrophils chiefly) (top right and middle right panels, respectively) in the mucosa
and submucosa. Note the significant reduction in the numbers of positively immunostained (cytoplasmic) macrophages and neutrophils in the ceca of H.
bilis-infected mice after treatment with clodronate liposomes in the middle panels compared to their respective placebo (PBS)-treated counterparts. Individual
bars represent the mean counts the SD (*, P
 0.05; **, P
 0.01; ***, P
 0.001). Scale bar, 40 	m.
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plexes, prostaglandins, G protein-coupled ligands, glucocortico-
ids, apoptotic cells, or the anti-inflammatory cytokine IL-10, the
result being an increase in IL-10 expression levels and the promo-
tion of Th2 helper T cell responses (2, 10, 19, 40). In a C57BL/6
IL-10/ mouse model of spontaneous enterocolitis, local mac-
rophage depletion via rectal administration of poly-D,L-lactic
acid microspheres containing dichloromethyl diphosphonate
(CL2MDP) attenuated chronic colitis, thus underlying the critical
role of resident gutmacrophages in the progression of IBD (50). In
the context of both commensal and pathogenic gut microflora,
certain populations of regulatory anti-inflammatory nonmigra-
tory intestinalmacrophages (F4/80Cd11bCd11c/) produce
IL-10 in the gut mucosa following recognition and activation by
pattern recognition receptors, such as TLRs, TLR agonists, and
nucleotide-binding oligomerization domains (NODs) (1, 5, 37).
This expression of IL-10 occurs via engagement ofv1 integrin, a
receptor for Sema7A that is expressed on the basolateral aspects of
the epithelial cells, and it has been shown that Sema7A-deficient
mice are prone to the development of severe DSS-induced colitis
due to a concomitant suppression of IL-10 (23).
In this study, on the basis of the increased gene expression
FIG 5 Relative mRNA levels of select inflammatory mediators in the ceca of Rag2/ mice. In each sample, the target gene mRNA was normalized to that of
GAPDH.Numbers on the left represent themean fold change of the individualmRNA levels in reference to the control group (defined as 0,meaning no change).
Bars represent the SD. The P values forH. bilis-infectedRag2/mice treated with placebo (PBS liposomes, n 13) or clodronate liposomes (n 13) compared
to the sham (uninfected Rag2/) controls (n 4) are indicated (*, P
 0.05; **, P
 0.01; ***, P
 0.001).
FIG 6 Colonization levels of cecalH. bilis estimated by quantitative PCR at 16
wpi. Numbers on the y axis represent copy numbers of theH. bilis genome per
	g ofmouse DNA in the corresponding samples. *, P
 0.05; **, P
 0.01; ***,
P
 0.001.
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levels of TNF- and IL-1 in associationwithH. bilis colonization
in Rag2/mice, it is assumed that CAMs were the primary acti-
vated macrophages during H. bilis infection with a concomitant
unsuccessful host immune-driven compensatory activation of
regulatory macrophages and enhanced IL-10 expression. Clodro-
nate treatment is presumed to have affected all classes of macro-
phages, as well as DCs, and thus both pro- and anti-inflammatory
(IL-10) macrophage-related cytokines mRNA levels were sup-
pressed in the cecum. On a similar note, systemic administration
of clodronate-coated liposomes during H. pylori infection in a
Mongolian gerbil model of gastritis and gastric carcinoma re-
sulted in a net beneficial effect, as demonstrated by a reduction of
both infiltrating macrophages and neutrophils with an associated
decrease inmacrophage activation-relatedNF-B-regulated cyto-
kine expression levels in the stomach, although its concomitant
effect on bacterial colonization dynamics, if any, was not studied
(54). In a recent pertinent study exploitingH. bilis adoptive trans-
fer procedures in CD11cTg/Rag2/mice, it was shown that DCs
expressing major histocompatibility complex II alone were suffi-
cient to trigger colitis in the presence of H. bilis and T cells (30).
Although the precise contribution of DCs was not explored in our
study, we believe that these cells also play a role complementary to
that of macrophages during H. bilis-induced typhlocolitis, and
clodronate treatment also affected DCs along with macrophages.
IL-1 is an important proinflammatory mediator in inflamma-
tion and autoimmune disease and is produced in two isoforms,
IL-1 and IL-1; IL-1 is secreted by classically activated macro-
phages and is also an inducer of Cox2 (17). In a TLR5 KO mouse
model of colitis, IL-1 was shown to be the primary mediator of
proinflammatory immune dysregulation (3). CXCL1 (a neutro-
phil chemoattractant produced bymacrophages, neutrophils, and
epithelial cells) was shown to be upregulated during acute DSS-
induced colitis in mice, along with other chemokines, such as
CXCL2/3, CXCL10, CCL2, CCL4, and CCL22, and an associated
downregulation of PGE2 (31) in a manner similar to that encoun-
tered in IBD patients (6). Reactive oxidative and nitrogen species
have been long been incriminated as key players in inflammation-
driven epithelial and subcellular molecular defects/mutations in
both human patients and animal models (2, 7, 21, 26, 33). In aH.
hepaticus-mediated 129/SvEvRag2/mousemodel of colitis and
colon cancer, it was shown that nitric oxide (NO) and TNF-
trigger colonic inflammation and carcinogenesis and a synthetic
iNOS inhibitor prevented NO production, suppressed mucosal
pathology, and inhibited carcinogenesis (7). Also, this increased
iNOS expression and cancer formation required the presence of
Gr-1 neutrophils and an enhanced level of TNF- expression in
the colon,whereas IL-10 downregulatedTNF- and iNOS expres-
sion (7). Similarly, TNF-, NO, and iNOS levels, as well as MPO
levels, are frequently elevated in biopsy samples frompatientswith
IBD (2, 21, 33, 48, 53).
A surprising observation in the present study was the negative
effect of systemic macrophage depletion on H. bilis colonization
levels in Rag2/mice; this finding contrasted with the unaltered
H. bilis colonization levels in their WT mouse counterparts. In
both Rag2/ and WT mice, our macrophage depletion strategy
was performed in the context of an established H. bilis infection
(15wpi) bywhich time significant typhlocolitis is observed only in
Rag2/mice. A direct correlation betweenmacrophage numbers
(systemic/local) andH. bilis colonization density in the immuno-
deficient setting of Rag2/ mice highlights the importance of
both macrophages and bacteria, i.e., H. bilis, in the promotion of
an inflammatory IBD-like state in this experimental model. Bac-
terial colonization levels following clodronate liposome-mediated
macrophage depletion has not explored in relation to typhlocolitis
models in mice, particularly with respect to enteric Helicobacter
spp. The in vivo interaction between macrophages and H. bilis,
along with a detailed microbial analysis of other gut flora, will be
required to determine whether H. bilis colonization levels were
transient or prolonged after macrophage depletion.
In conclusion, using a Rag2/ mouse model of H. bilis-in-
duced typhlocolitis, we have shown that systemic depletion of
macrophages imparts a net positive anti-inflammatory effect by
amelioration of typhlocolitis with a concomitant reduction in in-
testinal macrophages and MPO neutrophils, as well as the sup-
pression of macrophage-related cytokines (IL-1, IL-10, TNF-,
iNOS, and CXCL1). The data from our study are particularly rel-
evant in the context of understanding the complexity of gut mi-
crobe-host immune homeostasis in the pathophysiology of IBD
and for developing future novel therapeutic strategies.
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